{
  "dataset": "Strategic Signal — Corporate AI Data Transactions",
  "dataset_version": "1.0.23",
  "methodology_version": "1.0.0",
  "released_on": "2026-10-27",
  "observation_count": 23,
  "approved_record_count": 18,
  "change_type": "reviewed_addition",
  "previous_version": "1.0.22",
  "changes": [
    "SS-AIDT-2026-0021: Owner-approved publication under the locked methodology: Tempus licenses up to 500,000 de-identified neurology records and the Tempus Agent to Pathos over five years, with up to $55 million in disclosed fees and explicit sublicense rights to BMS. Realized delivery and training rights remain undisclosed."
  ],
  "known_limits": [
    "Only human_reviewed records count as approved observations.",
    "Bundled commitments and pending bids are not dataset purchase prices."
  ]
}